… first study to demonstrate adverse effects conducted a retrospective analysis of 507 patients
… , ie, differences between the two groups were statistically significant regardless of the …

… of all adverse events for high-dose regimens of erlotinib and … achieved higher concentrations
in CSF compared to standard … gefitinib at the dose of 750 mg OD for safety and efficacy in …

… This study aimed to describe efficacy and safety of epidermal … and safety of EGFR-TKIs were
compared. Univariate and … ≥3 adverse events than those treated with gefitinib and erlotinib, …

… treatment of patients with non-small cell lung cancer that … differences among adverse
effects frequency between groups. … In this retrospective study, we aimed to analyze the cost of …

… -dose erlotinib was 60.0%, while the adverse events observed … no difference in plasma
erlotinib concentration between the … -dose erlotinib was associated with efficacy and safety in frail …

… the difference in the overall survival time (OS) among the 3 … -line therapy with gefitinib was
effective in super-elderly patients with … incidence of severe adverse events. In addition, 36% of …

… retrospective studies. The overall consensus based on the end outcome of each published
journal on the effectiveness of gefitinib … Majr] OR "Gefitinib/adverse effects"[Majr] OR "Gefitinib/…

… anti-tumor activity in patients with advanced non-small cell lung … Methods: We conducted a
retrospective study on the patients … -related adverse events were reported in 18.76% patients. …

… Chest CT scanning showed diffuse GGO in both lungs (grade 2 adverse event) and …
LUX-Lung 7 study comparing afatinib and gefitinib, although there was no significant difference in …

SciELO - Brasil - Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced
non-small-cell lung cancer: A meta analysis Comparison of gefitinib plus chemotherapy …